CETP inhibitors (Bayer/Merck)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCETP inhibitors (Bayer/Merck)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsLipid Metabolism DisordersAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co IncBayer AG
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A